MORTIMER IAN Insider Trading Activity

Average Profitability
28.18%
Insider Buys Quantity
2
Insider Buys Sum
$146,180.00
Insider Sells Quantity
4
Insider Sells Sum
$3.52M

Insider Activity of MORTIMER IAN

According to the SEC Form 4 filings, MORTIMER IAN, being in a position of

  1. PRESIDENT & CEO at Xenon Pharmaceuticals Inc.,
    оver the last 12 months, has bought 30000 shares for $1.12M, and sold 353879 shares for $20.29M,
    over all time since 2016-06-24, has bought 69600 shares for $1.27M, and sold 465534 shares for $24.82M.

Biography of MORTIMER IAN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$1,121,400113
Sells
$20,294,056788

Comparison of Insiders on Amount of Buys and Sells

2026-09-30PurchaseXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
30,000
0.0312%
$37.38$1.12M-2.38%
2026-03-13SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
7,308
0.0088%
$55.23$403,584+1.43%
2026-03-10SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
11,269
0.014%
$60.11$677,357-7.54%
2026-03-09SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
270,000
0.5026%
$60.33$16.29M-10.64%
2026-01-02SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
40,000
0.0513%
$44.43$1.78M+22.96%
2025-12-08SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
10,830
0.0144%
$45.73$495,207+21.65%
2025-12-05SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
14,375
0.0186%
$45.03$647,306+20.3%
2025-11-28SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
97
0.0001%
$45.01$4,366+20.71%
2025-10-01SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT, CEO & INTERIM CFO
25,000
0.0324%
$40.16$1M+34.94%
2025-01-27SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
16,315
0.0216%
$40.50$660,806-5.71%
2025-01-24SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
22,468
0.0298%
$40.20$903,214-5.41%
2025-01-23SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
16,217
0.0213%
$40.08$649,977-5.4%
2023-05-24SaleXenon Pharmaceuticals Inc.
XENE
PRESIDENT & CEO
31,655
0.0482%
$41.41$1.31M-4.09%
2017-08-10PurchaseXenon Pharmaceuticals Inc.
XENE
CFO & COO
30,000
0.1747%
$2.88$86,450+28.18%
2016-06-24PurchaseXenon Pharmaceuticals Inc.
XENE
CFO & COO
9,600
0.0658%
$6.22$59,730+24.76%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.